Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Gram-Negative Bacterial Infections
Description
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method. MeSH
Hierarchy View
Subtype Terms (31)
Brucellosis
1 approved drug
Burkholderia Infections
6 drugs (4 approved, 2 experimental)
Campylobacter Infections
12 drugs (3 approved, 9 experimental)
Enterobacteriaceae Infections
18 drugs (17 approved, 1 experimental)
Helicobacter Infections
27 drugs (23 approved, 4 experimental)
Lyme Disease
19 drugs (13 approved, 6 experimental)
Neisseriaceae Infections
6 drugs (5 approved, 1 experimental)
Piscirickettsiaceae Infections
Pseudomonas Infections
22 drugs (19 approved, 3 experimental)
Q Fever
2 drugs (1 approved, 1 experimental)
Spirochaetales Infections
1 approved drug
Tularemia
6 drugs (3 approved, 3 experimental)
Vibrio Infections
5 experimental drugs
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (2)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
